학술논문
9007 ORAL Phase II Study of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker, in Patients With EGFR FISH-positive Advanced NSCLC
Document Type
Abstract
Author
Source
Subject
Language
ISSN
0959-8049